Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y013577 | — |
Nurse Practitioner calling to report inadvertently administering a PROQUAD vaccine after experiencing a temperature excursion. Product was supported. See TE Case# 02848877. Permission to contact HCP was granted. Additional AE Case# 02848880 filed. No; no additional asdverse event eported; Information has been received from Business Partner/CRO on 31-Jul-2025. This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT) . On an unknown date, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013577, expiration date: 03-Feb-2026) for an unknown indication. This vaccine underwent temperature excursion in 17 degree Fahrenheit for 1 hour 45 minutes and in 15 degree Fahrenheit for 30 minutes (Improper storage of product in use). No additional adverse event was reported.
sterile diluent